Aurobindo Pharma hits 52-week low, slips 25% in one month

Shares of Aurobindo Pharma hit a fresh 52-week low of Rs 728.50 as they fell 3.4 per cent on the BSE in intra-day trade on Tuesday. The stock of the pharmaceutical company has declined 12 per cent in the past three trading days after the company reported a disappointing operational performance in the June 2021 quarter (Q1FY22), amid a decline across the US market and antiretroviral (ARVs). The stock of the pharmaceutical company was trading at its lowest level since June 2020. In the past one month, it has lost 25 per cent, as compared to a 4.4 per cent